Ref.: BL-RE-106337Manufacturer ref.: EH460RBX10 10 x 96 tests
Price on request
Custom pricing depending on configuration and quantity.
TLR4 is part of the Toll-type receptor family (TLR) that plays a fundamental role in the recognition of pathogens and the activation of innate immunity. TLR are highly conserved from Drosophil to humans and are...
TLR4 is part of the Toll-type receptor family (TLR) that plays a fundamental role in the recognition of pathogens and the activation of innate immunity. TLR are highly conserved from Drosophil to humans and are...
TLR4 is part of the Toll-type receptor family (TLR) that plays a fundamental role in the recognition of pathogens and the activation of innate immunity. LRTs are highly conserved from the Drosophile to humans and share structural and functional similarities. This receptor is expressed in abundance in the placenta and myelomocytic subpopulation of leukocytes. Mammal cells react to LPS by activating TLR4. TLR4 is part of the lipopolysaccharide receptor (LPS) multiprotein complex containing CD14, LY96, and TLR4, and is involved in the lipopolysaccharide (LPS)-induced signal transduction events found in most Gram-negative bacteria. TLR4 facilitates the recognition of pathogenic-associated molecular profiles (PAMPs) that are expressed on infectious agents and mediate the production of cytokines necessary for the development of effective immunity. The various LRTs have different modes of expression. TLR4 mutations were associated with differences in LPS reactivity. Several variants of transcription of the TLR4 gene were found, but the coding potential of most proteins is uncertain. TLR4 is expressed by peripheral blood monocytes and a small population of B cells and is also expressed in the human placenta. Studies with mice with LRT4 deficiency indicate that the primary LRT ligand is lipopolysaccharide. Therefore, these mice also showed increased sensitivity to Gram-negative septicemia.
Sensitivity
Sensitivity of the dosage: 0.4 ng/ml.
Measurement range
Dose range: 0.4 to 100 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Reproducibility
Coefficient of intradose variation < 10%, interdose < 12%.
Target
Target: TLR4 (CD284).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17747813
Specifications
Accession number
O00206
Dose range
0.4 to 100 ng/ml
Sensitivity of the dosage
0.4 ng/ml
Conjugate
Biotin
Product type
ELISA
Type of sample
Plasma, Serum, Surnatant
For use with (equipment)
Colorimetric microplate reader
Genetic identification (Enter)
7099
Gene symbol(s)
TLR4
Coefficient of inter-dose variation
< 12%
Coefficient of intra-dose variation
< 10%
Contents of kits
96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate.
Marker or dye
HRP
Quantity
10 x 96 tests
Regulatory status
RUO
Target
TLR4 (CD284)
Test time
1 h 20 min
Physical characteristics
Volume of sample
Serum, 50 μl-Surnatant, 50 μl-Plasma, 50 μl
Storage and shipping
Storage conditions
2°C to 8°C
Total duration of dosing
4 h 45 min
Origin and customs
Manufacturer ref.
EH460RBX10
Country of origin
United States
HS customs code
3002 12 00 00
A question or a specific configuration? Contact us for a quote.